US equities |
MU $1,083.23 ▼-0.44% META $723.95 ▲+0.37% NVDA $234.63 ▼-1.20% PLTR $201.66 ▲+3.88% GOOGL $353.71 ▲+0.92% SNDK $1,669.50 ▼-1.35% INTC $110.23 ▼-2.55% AMD $634.41 ▼-1.77%
FinancialContent

Latest News about Nanomerics

Recent news which mentions Nanomerics

Virpax Pharmaceuticals 2022 R&D Expenses Grow 122% To $10.8M, Here Are The Details
Tickers VRPX
Tags VRPX Market News Penny Stocks
From Benzinga
Virpax Completes FDA Required Preclinical Toxicology Studies For Its Licensed Molecular Envelope Technology
Tickers VRPX
Tags News Nanomerics Jeffrey Murray
From Benzinga
Virpax Receives pre-IND Application Guidance From The FDA For Its CBD-Based Drug Candidate For Epilepsy
Tickers VRPX
Tags premium Sheila A/ Mathias Markets
From Benzinga